These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12555141

  • 1. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG, Gunasinghe H, Sprunger PD, Baskin JM, Bradham WC.
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [Abstract] [Full Text] [Related]

  • 2. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ, Zhang X, Zhu WL, Huang Y.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1693-6. PubMed ID: 16854324
    [Abstract] [Full Text] [Related]

  • 3. Novel approaches to retard ventricular remodeling in heart failure.
    Spinale FG.
    Eur J Heart Fail; 1999 Mar 27; 1(1):17-23. PubMed ID: 10937974
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinases: regulation and dysregulation in the failing heart.
    Spinale FG.
    Circ Res; 2002 Mar 22; 90(5):520-30. PubMed ID: 11909815
    [Abstract] [Full Text] [Related]

  • 5. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
    Deschamps AM, Spinale FG.
    Cardiovasc Res; 2006 Feb 15; 69(3):666-76. PubMed ID: 16426590
    [Abstract] [Full Text] [Related]

  • 6. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW, Verma S, Weisel RD, Li RK.
    Cardiovasc Pathol; 2005 Feb 15; 14(2):49-60. PubMed ID: 15780796
    [Abstract] [Full Text] [Related]

  • 7. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG.
    Physiol Rev; 2007 Oct 15; 87(4):1285-342. PubMed ID: 17928585
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP, Creemers EE.
    J Card Fail; 2002 Dec 15; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [Abstract] [Full Text] [Related]

  • 10. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
    Seeland U, Kouchi I, Zolk O, Itter G, Linz W, Böhm M.
    J Mol Cell Cardiol; 2002 Feb 15; 34(2):151-63. PubMed ID: 11851355
    [Abstract] [Full Text] [Related]

  • 11. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP, Huang CY, Wang JS, Sun PC, Shih CC.
    Ann Thorac Surg; 2008 Oct 15; 86(4):1243-9. PubMed ID: 18805169
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR.
    Circulation; 2006 May 02; 113(17):2089-96. PubMed ID: 16636176
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF, Sun J, Lemaitre V, D'Armiento JM.
    Hypertens Res; 2008 Apr 02; 31(4):725-35. PubMed ID: 18633185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM, Yang LX, Zhu SJ, Yang YJ, Guo CM, Qi F, Wei L, Shi YK, Wang Y, Ren L.
    Zhonghua Nei Ke Za Zhi; 2004 Nov 02; 43(11):828-31. PubMed ID: 15634542
    [Abstract] [Full Text] [Related]

  • 18. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG, Coker ML, Bond BR, Zellner JL.
    Cardiovasc Res; 2000 May 02; 46(2):225-38. PubMed ID: 10773226
    [Abstract] [Full Text] [Related]

  • 19. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R, Jacob MP, Prunier F, Angles-Cano E, Mercadier JJ, Michel JB.
    J Mol Cell Cardiol; 2005 Jan 02; 38(1):193-204. PubMed ID: 15623436
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
    Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1609-18. PubMed ID: 15489093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.